RU2018101431A - Ингибиторы индоламин-2,3-диоксигеназы - Google Patents
Ингибиторы индоламин-2,3-диоксигеназы Download PDFInfo
- Publication number
- RU2018101431A RU2018101431A RU2018101431A RU2018101431A RU2018101431A RU 2018101431 A RU2018101431 A RU 2018101431A RU 2018101431 A RU2018101431 A RU 2018101431A RU 2018101431 A RU2018101431 A RU 2018101431A RU 2018101431 A RU2018101431 A RU 2018101431A
- Authority
- RU
- Russia
- Prior art keywords
- compound
- formula
- pharmaceutically acceptable
- acceptable salt
- indolamin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic Table
- C07F5/02—Boron compounds
- C07F5/025—Boronic and borinic acid compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/22—Boron compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Virology (AREA)
- Transplantation (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Molecular Biology (AREA)
- Tropical Medicine & Parasitology (AREA)
- AIDS & HIV (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201562187937P | 2015-07-02 | 2015-07-02 | |
| US62/187,937 | 2015-07-02 | ||
| PCT/IB2016/053947 WO2017002078A1 (en) | 2015-07-02 | 2016-06-30 | Inhibitors of indoleamine 2,3-dioxygenase |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RU2018101431A true RU2018101431A (ru) | 2019-08-05 |
Family
ID=56363880
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2018101431A RU2018101431A (ru) | 2015-07-02 | 2016-06-30 | Ингибиторы индоламин-2,3-диоксигеназы |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US10239894B2 (enExample) |
| EP (1) | EP3317287B1 (enExample) |
| JP (1) | JP6654208B2 (enExample) |
| KR (1) | KR20180022988A (enExample) |
| CN (1) | CN107709338A (enExample) |
| AU (1) | AU2016285483B2 (enExample) |
| BR (1) | BR112017028456A2 (enExample) |
| CA (1) | CA2990335A1 (enExample) |
| ES (1) | ES2752455T3 (enExample) |
| RU (1) | RU2018101431A (enExample) |
| WO (1) | WO2017002078A1 (enExample) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108530444B (zh) * | 2018-06-11 | 2021-08-24 | 药康众拓(江苏)医药科技有限公司 | 一种新型nampt和ido双重抑制剂及其制备方法和医药用途 |
| EP3873608A1 (en) | 2018-10-31 | 2021-09-08 | Gilead Sciences, Inc. | Substituted 6-azabenzimidazole compounds having hpk1 inhibitory activity |
| EP4371987B9 (en) | 2018-10-31 | 2025-11-26 | Gilead Sciences, Inc. | Substituted 6-azabenzimidazole compounds as hpk1 inhibitors |
| US11453681B2 (en) | 2019-05-23 | 2022-09-27 | Gilead Sciences, Inc. | Substituted eneoxindoles and uses thereof |
| CN110156629A (zh) * | 2019-05-30 | 2019-08-23 | 广州药本君安医药科技股份有限公司 | 丙卡巴肼的合成方法 |
| BR112023017582A2 (pt) | 2021-03-05 | 2023-12-05 | Univ Basel | Composições para o tratamento de doenças ou condições associadas ao ebv |
| EP4052705A1 (en) | 2021-03-05 | 2022-09-07 | Universität Basel Vizerektorat Forschung | Compositions for the treatment of ebv associated diseases or conditions |
| CN122374319A (zh) * | 2023-12-04 | 2026-07-10 | 珠海联邦制药股份有限公司 | 硼酸类β-内酰胺酶抑制剂及其制备方法和应用 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB427857A (en) | 1934-08-02 | 1935-05-01 | Newsum Sons & Company Ltd H | A new or improved system of construction for skeleton structures, particularly vehicle body frames and door frames |
| US4107288A (en) | 1974-09-18 | 1978-08-15 | Pharmaceutical Society Of Victoria | Injectable compositions, nanoparticles useful therein, and process of manufacturing same |
| US5145684A (en) | 1991-01-25 | 1992-09-08 | Sterling Drug Inc. | Surface modified drug nanoparticles |
| WO2002074769A1 (en) | 2001-03-19 | 2002-09-26 | Ono Pharmaceutical Co., Ltd. | Drugs containing triazaspiro[5.5]undecane derivatives as the active ingredient |
| DK1879573T3 (da) * | 2005-05-10 | 2013-02-25 | Incyte Corp | Modulatorer af indolamin 2,3-dioxygenase og fremgangsmåder til anvendelse deraf |
| CA2822094C (en) | 2005-08-31 | 2015-10-27 | Celgene Corporation | Isoindole-imide compounds and compositions comprising and methods of using the same |
| CA3012229C (en) * | 2008-07-08 | 2020-11-10 | Incyte Holdings Corporation | 1,2,5-oxadiazoles as inhibitors of indoleamine 2,3-dioxygenase |
| AU2011329485A1 (en) * | 2010-11-18 | 2013-04-18 | Glaxo Group Limited | Compounds |
| CA2889182A1 (en) | 2012-10-26 | 2014-05-01 | The University Of Chicago | Synergistic combination of immunologic inhibitors for the treatment of cancer |
-
2016
- 2016-06-30 WO PCT/IB2016/053947 patent/WO2017002078A1/en not_active Ceased
- 2016-06-30 US US15/578,861 patent/US10239894B2/en not_active Expired - Fee Related
- 2016-06-30 RU RU2018101431A patent/RU2018101431A/ru not_active Application Discontinuation
- 2016-06-30 BR BR112017028456A patent/BR112017028456A2/pt not_active Application Discontinuation
- 2016-06-30 CA CA2990335A patent/CA2990335A1/en not_active Abandoned
- 2016-06-30 KR KR1020187003254A patent/KR20180022988A/ko not_active Withdrawn
- 2016-06-30 CN CN201680039221.7A patent/CN107709338A/zh active Pending
- 2016-06-30 AU AU2016285483A patent/AU2016285483B2/en not_active Ceased
- 2016-06-30 ES ES16735943T patent/ES2752455T3/es active Active
- 2016-06-30 JP JP2017568056A patent/JP6654208B2/ja not_active Expired - Fee Related
- 2016-06-30 EP EP16735943.9A patent/EP3317287B1/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| EP3317287B1 (en) | 2019-07-31 |
| WO2017002078A1 (en) | 2017-01-05 |
| CN107709338A (zh) | 2018-02-16 |
| ES2752455T3 (es) | 2020-04-06 |
| CA2990335A1 (en) | 2017-01-05 |
| EP3317287A1 (en) | 2018-05-09 |
| US10239894B2 (en) | 2019-03-26 |
| JP6654208B2 (ja) | 2020-02-26 |
| US20180298035A1 (en) | 2018-10-18 |
| AU2016285483A1 (en) | 2018-01-04 |
| JP2018521056A (ja) | 2018-08-02 |
| AU2016285483B2 (en) | 2018-07-19 |
| KR20180022988A (ko) | 2018-03-06 |
| BR112017028456A2 (pt) | 2018-08-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CY1124592T1 (el) | Ζιζανιοκτονως δραστικα 3-φαινυλοïσοξαζολινο-5-καρβοξαμιδια αποτελουμενα απο τετραϋδρο- και διυδροφουρανοκαρβοξυλικα οξεα και εστερες | |
| MX2021013075A (es) | Oxisteroles y metodos de uso de los mismos. | |
| PH12016501813A1 (en) | 1,3-benzodioxole derivative | |
| MX390081B (es) | Compuesto farmacéutico. | |
| MX376833B (es) | Oxiesteroles y metodos de uso de los mismos. | |
| MX385158B (es) | Derivados indol para uso en medicina. | |
| WO2017075629A3 (en) | Wee 1 kinase inhibitors and methods of making and using the same | |
| EA201792259A1 (ru) | Бензимидазольные и имидазопиридиновые карбоксимидамидные соединения | |
| JP2016515561A5 (enExample) | ||
| JP2012144574A5 (enExample) | ||
| EA201791420A1 (ru) | Соединения триазолопиримидина и их применения | |
| JP2015522045A5 (enExample) | ||
| EA202090291A3 (ru) | Производные бипиразола в качестве ингибиторов jak | |
| RU2020131276A (ru) | Терапевтические соединения и композиции | |
| RU2016150410A (ru) | Ингибиторы фактора xia | |
| CA3015494C (en) | Novel compositions and therapeutic methods | |
| EA201791289A1 (ru) | Ингибиторы клеточного некроза и связанные с ними способы | |
| EA201692550A1 (ru) | Соединения, содержащие систему 1,1',2,5'-тетрагидроспиро[индол-3,2'-пиррол]-2,5'-диона в качестве ингибиторов белок-белкового взаимодействия p53-mdm2 | |
| MX376283B (es) | Compuestos de imidazopiridazina. | |
| EA201492188A1 (ru) | Макроциклические ингибиторы вирусов flaviviridae | |
| RU2020108580A (ru) | Лекарственное соединение и способы его очистки | |
| JP2018521056A5 (enExample) | ||
| EA201700356A1 (ru) | Новые циклопропанбензофуранилпиридопиразиндионы | |
| EA201792264A1 (ru) | Способы лечения воспалительных заболеваний | |
| EA201650003A1 (ru) | Соединённые циклоалкилом дигетероциклические производные |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FA93 | Acknowledgement of application withdrawn (no request for examination) |
Effective date: 20190701 |